TCG NEWS
Mr. Jeff Goater joins The Column Group as Venture Partner
October 1, 2021
The Column Group announces the hiring of Mr. Jeff Goater. Previously, Mr. Goater served as Chief Executive Officer of Surface Oncology. Prior to Surface, he
Dr. Sarah Gillmor Hymowitz joins The Column Group as Venture Partner
September 13, 2021
The Column Group announces the hiring of Dr. Sarah Gillmor Hymowitz. Previously, Dr. Hymowitz spent 22 years at Genentech rising to Vice President of Protein
TCG Launches the Swanson Fellowship Program and Dr. Tobias Schmid joins as first Fellow
September 7, 2021
Widely considered to be the father of the biotechnology industry, Robert Swanson changed the world when he founded Genentech with Herbert Boyer in 1976. TCG’s
TCG Announces the Addition of TCG iPartners
April 1, 2021
TCG’s iPartners represents a new ideation advisory group comprised of leading academic investigators and biotech entrepreneurs. Working closely with TCG’s Swanson Fellows and our core
